We next tested whether RANK loss exclusively in tumor cells could alter tumor immune infiltration: tumors derived from PyMT/RANK−/− mice (RANK−/− tumors) were orthotopically transplanted in syngeneic C57Bl6 mice and compared with RANK+/+ tumor transplants. This evidence concerns the gene TNFRSF11A and neoplasm.